Meg Caroline Doherty

Assistant Professor

19942019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Meg Caroline Doherty is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
HIV Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Meta-Analysis Medicine & Life Sciences
Guidelines Medicine & Life Sciences
Drug Users Medicine & Life Sciences
HIV Infections Medicine & Life Sciences
Tenofovir Medicine & Life Sciences
Drug Resistance Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1994 2019

Curbing the rise of HIV drug resistance in low-income and middle-income countries: the role of dolutegravir-containing regimens

Inzaule, S. C., Hamers, R. L., Doherty, M. C., Shafer, R. W., Bertagnolio, S. & Rinke de Wit, T. F., Jul 1 2019, In : The Lancet Infectious Diseases. 19, 7, p. e246-e252

Research output: Contribution to journalReview article

Drug Resistance
HIV
Reverse Transcriptase Inhibitors
dolutegravir
Viral Load

Current and future priorities for the development of optimal HIV drugs

Vitoria, M., Rangaraj, A., Ford, N. & Doherty, M. C., Mar 1 2019, In : Current Opinion in HIV and AIDS. 14, 2, p. 143-149 7 p.

Research output: Contribution to journalArticle

HIV
Pharmaceutical Preparations
International Agencies
Therapeutics
Referral and Consultation

Do Quality Improvement Initiatives Improve Outcomes for Patients in Antiretroviral Programs in Low- and Middle-Income Countries? A Systematic Review

Hargreaves, S., Rustage, K., Nellums, L. B., Bardfield, J. E., Agins, B., Barker, P., Massoud, M. R., Ford, N. P., Doherty, M. C., Dougherty, G. & Singh, S., Aug 15 2019, In : Journal of acquired immune deficiency syndromes (1999). 81, 5, p. 487-496 10 p.

Research output: Contribution to journalArticle

Quality Improvement
Viral Load
HIV
PubMed
MEDLINE

Increasing levels of pretreatment HIV drug resistance and safety concerns for dolutegravir use in women of reproductive age

Inzaule, S. C., Jordan, M. R., Cournil, A., Vitoria, M., Ravasi, G., Cham, F., Le, L. V., Dzangare, J., Hamunime, N., Mutenda, N., Aghokeng, A., Bissek, A., Billong, S., Kaleebu, P., Doherty, M. C. & Bertagnolio, S., Sep 1 2019, In : AIDS. 33, 11, p. 1797-1799 3 p.

Research output: Contribution to journalArticle

Reverse Transcriptase Inhibitors
Drug Resistance
HIV
Safety
Therapeutics

Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defects

Mofenson, L. M., Pozniak, A. L., Wambui, J., Raizes, E., Ciaranello, A., Clayden, P., Ehrenkranz, P., Fakoya, A., Hill, A., Khoo, S., Mahaka, I., Modi, S., Moore, C., Phillips, A., Siberry, G., Sikwese, K., Thorne, C., Watts, H. D., Doherty, M. C. & Ford, N. P., Jul 1 2019, In : Journal of the International AIDS Society. 22, 7, p. e25352

Research output: Contribution to journalArticle

Open Access
Neural Tube Defects
Safety
Pregnancy
Pharmaceutical Preparations
Botswana